| NCT05110768 | Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy | UNKNOWN | PHASE2 | 2021-11-30 | 2022-05-30 | 2022-04-30 |
| NCT04689932 | Triferic AVNU Infusion Via Freedom Pump During Hemodialysis | COMPLETED | PHASE4 | 2021-04-19 | 2021-06-19 | 2021-06-19 |
| NCT04239391 | Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC) | UNKNOWN | PHASE3 | 2020-09-01 | 2023-11-01 | 2023-08-31 |
| NCT04409132 | Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus. | COMPLETED | PHASE1, PHASE2 | 2020-06-25 | 2021-04-02 | 2021-04-02 |
| NCT04042324 | A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients | COMPLETED | PHASE1, PHASE2 | 2019-09-30 | 2020-01-16 | 2020-01-16 |
| NCT03303144 | Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients | COMPLETED | PHASE1, PHASE2 | 2017-10-01 | 2017-12-28 | 2017-12-28 |
| NCT02905981 | Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol | TERMINATED | PHASE2 | 2017-01-17 | 2018-03-15 | 2018-03-15 |
| NCT02909153 | Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis | COMPLETED | PHASE1 | 2017-01 | 2017-07 | 2017-07 |
| NCT02739100 | Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients | COMPLETED | PHASE1 | 2016-04 | 2016-07 | 2016-07 |
| NCT02767128 | Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers | COMPLETED | PHASE1 | 2016-04 | 2016-04 | 2016-04 |
| NCT02595437 | Triferic Pediatric Pharmacokinetic Protocol | COMPLETED | PHASE1, PHASE2 | 2015-11-01 | 2017-01 | 2016-12 |
| NCT02636049 | Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Intravenously to Healthy Adult Volunteers | COMPLETED | PHASE1 | 2015-10 | 2015-10 | 2015-10 |
| NCT01894906 | Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients | COMPLETED | PHASE1, PHASE2 | 2013-07 | 2013-09 | 2013-09 |
| NCT01920854 | A Single Ascending Dose Study of Soluble Ferric Pyrophosphate Administered Intravenously in Healthy Volunteers. | COMPLETED | PHASE1 | 2013-06 | 2013-09 | 2013-09 |
| NCT01503021 | Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis | COMPLETED | PHASE3 | 2011-11 | 2014-01 | 2014-01 |
| NCT01322347 | Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2) | COMPLETED | PHASE3 | 2011-04 | 2014-02 | 2014-01 |
| NCT01320202 | Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients | COMPLETED | PHASE3 | 2011-03 | 2013-11 | 2013-05 |
| NCT01286012 | Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients | COMPLETED | PHASE2 | 2011-01 | 2013-01 | 2013-01 |
| NCT00548249 | Dose Ranging Study of Dialysate Containing Soluble Iron to Treat Subjects With End Stage Renal Disease (ESRD) Receiving Chronic Hemodialysis | COMPLETED | PHASE2 | 2007-08 | 2010-01 | 2009-10 |